Detalhe da pesquisa
1.
Canadian Consensus Guidelines for the Diagnosis and Treatment of Autoimmune Encephalitis in Adults.
Can J Neurol Sci
; : 1-21, 2024 Feb 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38312020
2.
A Quality Assessment of Aquaporin-4 & Myelin Oligodendrocyte Glycoprotein Antibody Testing.
Can J Neurol Sci
; 50(6): 861-869, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36398407
3.
Neuro-Behcet's Presenting as a Tumefactive Brainstem Mass.
Can J Neurol Sci
; 50(5): 787-789, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36184885
4.
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Myelitis Presenting with Headache.
Can J Neurol Sci
; 48(6): 879-881, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33568250
5.
Medical Tourism for CCSVI Procedures in People with Multiple Sclerosis: An Observational Study.
Can J Neurol Sci
; 43(3): 360-7, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-26891024
6.
Emergence of De Novo Conditions Following Remission of Cushing Syndrome: A Case Report and Scoping Review.
Endocrinol Diabetes Metab
; 7(3): e00476, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38597588
7.
MS patients report excellent compliance with oral prednisone for acute relapses.
Can J Neurol Sci
; 39(3): 352-4, 2012 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-22547517
8.
Complications in MS patients after CCSVI procedures abroad (Calgary, AB).
Can J Neurol Sci
; 38(5): 741-6, 2011 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-21856578
9.
Diagnosis and management of secondary-progressive multiple sclerosis: time for change.
Neurodegener Dis Manag
; 9(6): 301-317, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31769344
10.
Jerking & confused: Leucine-rich glioma inactivated 1 receptor encephalitis.
J Neuroimmunol
; 289: 84-6, 2015 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26616875
11.
Evolving role of MRI in optimizing the treatment of multiple sclerosis: Canadian Consensus recommendations.
Mult Scler J Exp Transl Clin
; 1: 2055217315589775, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-28607695
12.
Long-term persistence with injectable therapy in relapsing-remitting multiple sclerosis: an 18-year observational cohort study.
PLoS One
; 10(4): e0123824, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25867095
13.
Autologous mesenchymal stem cell therapy in progressive multiple sclerosis: an open label study.
Curr Stem Cell Res Ther
; 7(6): 407-14, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23061813